Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Introductory guidance on choosing long-term holds for beginners, focusing on fundamentals, liquidity, and project viability.
27,784 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Gap reported a Q4 beat on earnings but a sharp post-earnings slide as margins face tariff pressure. The company raise...
Publicly traded lenders, brokerages, and builders posted a mixed bag of Q1 2026 results as higher borrowing costs and...
The White House says the trip will be brief, while diplomats work toward a framework on Iran's nuclear program and re...
Oil crosses the critical $100 threshold as geopolitical tensions mount, sending Dow futures lower and pushing househo...
Markets wobbled as President Trump labeled Iran’s ceasefire reply 'TOTALLY UNACCEPTABLE,' fueling a risk-off mood ami...
A sharp selloff in optical interconnect makers hits Applied Optoelectronics as it plunges 13%, prompting questions ab...
Analysts lift HIMS, TDOC, and ALEC as strategic partnerships reduce key risks, prompting renewed upside potential and...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
Brent crude sits around $74 per barrel as of 8:45 a.m. ET on June 25, 2026, marking a quiet pause after recent volati...
As Sonida shares insights from the Q4 2025 earnings call, investors gain a clearer view of the company’s path through...
When a stock jumps in the morning, traders ask: what happened? This article explains why stock popped today can occur...